115 related articles for article (PubMed ID: 31740385)
1. Ajuba: An emerging signal transducer in oncogenesis.
Jia H; Peng H; Hou Z
Pharmacol Res; 2020 Jan; 151():104546. PubMed ID: 31740385
[TBL] [Abstract][Full Text] [Related]
2. The LIM protein Ajuba/SP1 complex forms a feed forward loop to induce SP1 target genes and promote pancreatic cancer cell proliferation.
Zhang B; Song L; Cai J; Li L; Xu H; Li M; Wang J; Shi M; Chen H; Jia H; Hou Z
J Exp Clin Cancer Res; 2019 May; 38(1):205. PubMed ID: 31101117
[TBL] [Abstract][Full Text] [Related]
3. The LIM protein AJUBA promotes colorectal cancer cell survival through suppression of JAK1/STAT1/IFIT2 network.
Jia H; Song L; Cong Q; Wang J; Xu H; Chu Y; Li Q; Zhang Y; Zou X; Zhang C; Chin YE; Zhang X; Li Z; Zhu K; Wang B; Peng H; Hou Z
Oncogene; 2017 May; 36(19):2655-2666. PubMed ID: 27893714
[TBL] [Abstract][Full Text] [Related]
4. Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis.
Chen X; Stauffer S; Chen Y; Dong J
J Biol Chem; 2016 Jul; 291(28):14761-72. PubMed ID: 27226586
[TBL] [Abstract][Full Text] [Related]
5. The Ajuba LIM domain protein is a corepressor for SNAG domain mediated repression and participates in nucleocytoplasmic Shuttling.
Ayyanathan K; Peng H; Hou Z; Fredericks WJ; Goyal RK; Langer EM; Longmore GD; Rauscher FJ
Cancer Res; 2007 Oct; 67(19):9097-106. PubMed ID: 17909014
[TBL] [Abstract][Full Text] [Related]
6. The LIM protein Ajuba influences interleukin-1-induced NF-kappaB activation by affecting the assembly and activity of the protein kinase Czeta/p62/TRAF6 signaling complex.
Feng Y; Longmore GD
Mol Cell Biol; 2005 May; 25(10):4010-22. PubMed ID: 15870274
[TBL] [Abstract][Full Text] [Related]
7. Ajuba, a cytosolic LIM protein, shuttles into the nucleus and affects embryonal cell proliferation and fate decisions.
Kanungo J; Pratt SJ; Marie H; Longmore GD
Mol Biol Cell; 2000 Oct; 11(10):3299-313. PubMed ID: 11029037
[TBL] [Abstract][Full Text] [Related]
8. LIM domain-containing protein Ajuba inhibits chemotherapy-induced apoptosis by negatively regulating p53 stability in colorectal cancer cells.
Xu B; Li Q; Zhang J; Chen F
Mol Oncol; 2023 Aug; 17(8):1678-1691. PubMed ID: 36931700
[TBL] [Abstract][Full Text] [Related]
9. The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression.
Hou Z; Peng H; Ayyanathan K; Yan KP; Langer EM; Longmore GD; Rauscher FJ
Mol Cell Biol; 2008 May; 28(10):3198-207. PubMed ID: 18347060
[TBL] [Abstract][Full Text] [Related]
10. The LIM protein Ajuba promotes adipogenesis by enhancing PPARγ and p300/CBP interaction.
Li Q; Peng H; Fan H; Zou X; Liu Q; Zhang Y; Xu H; Chu Y; Wang C; Ayyanathan K; Rauscher FJ; Zhang K; Hou Z
Cell Death Differ; 2016 Jan; 23(1):158-68. PubMed ID: 26113042
[TBL] [Abstract][Full Text] [Related]
11. Ajuba transactivates N-cadherin expression in colorectal cancer cells through interaction with Twist.
Wu Z; Zou X; Xu Y; Zhou F; Kuai R; Li J; Yang D; Chu Y; Peng H
J Cell Mol Med; 2021 Aug; 25(16):8006-8014. PubMed ID: 34173718
[TBL] [Abstract][Full Text] [Related]
12. A novel mechanism for activation of Aurora-A kinase by Ajuba.
Bai M; Ni J; Wu J; Wang B; Shen S; Yu L
Gene; 2014 Jun; 543(1):133-9. PubMed ID: 24680704
[TBL] [Abstract][Full Text] [Related]
13. AJUBA: A regulator of epidermal homeostasis and cancer.
Schleicher K; Schramek D
Exp Dermatol; 2021 Apr; 30(4):546-559. PubMed ID: 33372298
[TBL] [Abstract][Full Text] [Related]
14. Ajuba Preferentially Binds LXRα/RXRγ Heterodimer to Enhance LXR Target Gene Expression in Liver Cells.
Fan H; Dong W; Li Q; Zou X; Zhang Y; Wang J; Li S; Liu W; Dong Y; Sun H; Hou Z
Mol Endocrinol; 2015 Nov; 29(11):1608-18. PubMed ID: 26389695
[TBL] [Abstract][Full Text] [Related]
15. An emerging link between LIM domain proteins and nuclear receptors.
Sala S; Ampe C
Cell Mol Life Sci; 2018 Jun; 75(11):1959-1971. PubMed ID: 29428964
[TBL] [Abstract][Full Text] [Related]
16. Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3beta-mediated phosphorylation of beta-catenin.
Haraguchi K; Ohsugi M; Abe Y; Semba K; Akiyama T; Yamamoto T
Oncogene; 2008 Jan; 27(3):274-84. PubMed ID: 17621269
[TBL] [Abstract][Full Text] [Related]
17. AJUBA increases the cisplatin resistance through hippo pathway in cervical cancer.
Bi L; Ma F; Tian R; Zhou Y; Lan W; Song Q; Cheng X
Gene; 2018 Feb; 644():148-154. PubMed ID: 29126926
[TBL] [Abstract][Full Text] [Related]
18. AJUBA promotes the migration and invasion of esophageal squamous cell carcinoma cells through upregulation of MMP10 and MMP13 expression.
Shi X; Chen Z; Hu X; Luo M; Sun Z; Li J; Shi S; Feng X; Zhou C; Li Z; Yang W; Li Y; Wang P; Zhou F; Gao Y; He J
Oncotarget; 2016 Jun; 7(24):36407-36418. PubMed ID: 27172796
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
[TBL] [Abstract][Full Text] [Related]
20. LIM domain protein Trip6 has a conserved nuclear export signal, nuclear targeting sequences, and multiple transactivation domains.
Wang Y; Gilmore TD
Biochim Biophys Acta; 2001 Apr; 1538(2-3):260-72. PubMed ID: 11336797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
